Navigation Links
Inverness Medical Innovations Announces September Investor Conference Schedule
Date:9/10/2009

WALTHAM, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend several healthcare industry investor conferences during the month of September.

  • Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend the Morgan Stanley Global Healthcare Conference being held on September 14 and 15, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central. Mr. Zwanziger's presentation is scheduled for Monday, September 14, 2009 at 2:45 p.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the Morgan Stanley Conference website at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=IMA&item_id=2400719.
  • Mr. Zwanziger and Mr. Russell will attend the Stifel Nicolaus/Johns Hopkins Annual Healthcare Symposium being held at the Hilton, Baltimore, Maryland on Tuesday, September 15, 2009. This symposium will not be webcast.
  • Mr. Russell will attend ThinkEquity's 6(th) Annual Growth Conference being held at the St. Regis, San Francisco on Wednesday, September 16. Mr. Russell's presentation is scheduled for 9:30 a.m., and will not be webcast.
  • Mr. Zwanziger and Mr. Russell will attend the UBS Global Life Sciences Conference being held on September 21 through the 23, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central. Mr. Zwanziger's presentation is scheduled for Tuesday, September 22, 2009 at 11:30 a.m. and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the UBS Conference website at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=143_EFSBJ3O.

During their presentations, Mr. Zwanziger and Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcasts, may contain or constitute information that has not been disclosed previously. Replays of the webcasts will be available via the links indicated above for 30 days.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
2. Inverness Medical Innovations to Present at the Canaccord Adams Global Growth Conference on August 11, 2009
3. Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes
4. CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients
5. Inverness Medical Innovations Announces Second Quarter 2009 Results
6. Inverness Medical Innovations Proposes to Acquire Concateno plc
7. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
8. Inverness Medical Innovations to Present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009
9. Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009
10. Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes
11. Inverness Medical Innovations Announces First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA ... Training Institute Education Center headquartered in Northern California, has issued an important reminder ... at their worksites. Employers with workers exposed to high temperatures should establish ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: